Risk Factors for Cardiovascular Disease Among Thyroid Cancer Survivors: Findings From the Utah Cancer Survivors Study
- PMID: 29850817
- PMCID: PMC6915829
- DOI: 10.1210/jc.2017-02629
Risk Factors for Cardiovascular Disease Among Thyroid Cancer Survivors: Findings From the Utah Cancer Survivors Study
Abstract
Context: Thyroid cancer survivors are at high risk of developing multiple cardiac and vascular conditions as consequence of cancer diagnosis and treatment. However, it is still unclear how the baseline and prognostic factors, as well as cancer treatments, play a role in increasing cardiac and vascular disease risk among thyroid cancer survivors.
Objective: To investigate the association between potential risk factors, treatment effects, and cardiovascular disease (CVD) outcomes in thyroid cancer survivors.
Design, setting, patients: Primary thyroid cancer survivors, diagnosed from 1997 to 2012 (n = 3822), were identified using the statewide Utah Population Database. The medical records were used to ascertain information on risk factors and CVD outcomes. Cox proportional hazards models were used to assess the risk of CVD with baseline demographic data and clinical factors.
Results: Among thyroid cancer survivors, age and year at cancer diagnosis, cancer stage, sex, baseline body mass index, baseline comorbidities, and TSH suppression therapy were significantly associated with CVD risk 1 to 5 years after cancer diagnosis. Patients who were male, overweight or obese, older at cancer diagnosis, and diagnosed with cancer since 2005 had an increased risk of CVD compared with patients who were female, had a normal body mass index, were younger at cancer diagnosis, and diagnosed with cancer from 1997 to 1999. Administration of TSH suppression therapy, distant metastases at cancer diagnosis, and a higher Charlson comorbidity index score were associated with an increased CVD risk among thyroid cancer survivors.
Conclusions: Our findings suggest that examining the effect of thyroid cancer diagnosis, cancer treatment, and demographic characteristics on the risk of CVD is critical.
Figures
Similar articles
-
Aging-Related Disease Risks among Young Thyroid Cancer Survivors.Cancer Epidemiol Biomarkers Prev. 2017 Dec;26(12):1695-1704. doi: 10.1158/1055-9965.EPI-17-0623. Epub 2017 Nov 22. Cancer Epidemiol Biomarkers Prev. 2017. PMID: 29167277 Free PMC article.
-
Cardiovascular disease risk in long-term breast cancer survivors: A population-based cohort study.Cancer. 2022 Jul 15;128(14):2826-2835. doi: 10.1002/cncr.34224. Epub 2022 May 13. Cancer. 2022. PMID: 35561317 Free PMC article.
-
Pharmaceutically treated anxiety but not depression prior to cancer diagnosis predicts the onset of cardiovascular disease among breast cancer survivors.Breast Cancer Res Treat. 2017 Nov;166(1):259-266. doi: 10.1007/s10549-017-4387-1. Epub 2017 Jul 17. Breast Cancer Res Treat. 2017. PMID: 28717854 Free PMC article.
-
Adherence to cardiovascular disease risk factor medications among patients with cancer: a systematic review.J Cancer Surviv. 2023 Jun;17(3):595-618. doi: 10.1007/s11764-022-01212-0. Epub 2022 May 17. J Cancer Surviv. 2023. PMID: 35578150 Free PMC article. Review.
-
Cardiovascular Disease in Survivors of Childhood Cancer: Insights Into Epidemiology, Pathophysiology, and Prevention.J Clin Oncol. 2018 Jul 20;36(21):2135-2144. doi: 10.1200/JCO.2017.76.3920. Epub 2018 Jun 6. J Clin Oncol. 2018. PMID: 29874141 Free PMC article. Review.
Cited by
-
The association of diabetes mellitus and routinely collected patient-reported outcomes in patients with cancer. A real-world cohort study.Cancer Med. 2024 Oct;13(20):e70246. doi: 10.1002/cam4.70246. Cancer Med. 2024. PMID: 39445809 Free PMC article.
-
Incident Cardiovascular Disease Risk among Older Asian, Native Hawaiian and Pacific Islander Breast Cancer Survivors.Cancer Epidemiol Biomarkers Prev. 2024 Jan 9;33(1):126-135. doi: 10.1158/1055-9965.EPI-23-0679. Cancer Epidemiol Biomarkers Prev. 2024. PMID: 37843411 Free PMC article.
-
Association between thyroid cancer and cardiovascular disease: A meta-analysis.Front Cardiovasc Med. 2023 Mar 3;10:1075844. doi: 10.3389/fcvm.2023.1075844. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 36937933 Free PMC article.
-
Quality of Life of Survivors of Thyroid Cancer Is Not Inferior to That in Subjects without Cancer: Long-Term after Over 5 Years.Endocrinol Metab (Seoul). 2022 Aug;37(4):664-673. doi: 10.3803/EnM.2022.1499. Epub 2022 Aug 29. Endocrinol Metab (Seoul). 2022. PMID: 36065647 Free PMC article.
-
The Effect of Gout on Thyroid Cancer Incidence: A Nested Case-Control Study Using a National Health Screening Cohort.J Pers Med. 2022 May 27;12(6):887. doi: 10.3390/jpm12060887. J Pers Med. 2022. PMID: 35743671 Free PMC article.
References
-
- National Cancer Institute. Surveillance, Epidemiology, and End Results (SEER) program: Cancer Stat Facts: Thyroid Cancer. Available at: seer.cancer.gov/statfacts/html/thyro.html. Accessed 18 January 2017.
-
- National Cancer Institute. State Cancer Profiles. Available at: statecancerprofiles.cancer.gov/. Accessed 28 June 2017.
-
- Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 2014;74(11):2913–2921. - PubMed
-
- Miller KD, Siegel RL, Lin CC, Mariotto AB, Kramer JL, Rowland JH, Stein KD, Alteri R, Jemal A. Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin. 2016;66(4):271–289. - PubMed
-
- NCCN Clinical Practice Guidelines in Oncology. Thyroid Carcinoma. 2017. Available at: www.nccn.org/professionals/physician_gls/pdf/thyroid.pdf. Accessed 29 November 2017.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
